Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.005 per share
Symbol
ERNA on Nasdaq
Shares outstanding
110,002,045
Price per share
$0.18
Price from insider filings
$0.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cherington Charles 38% +15% $8,755,063 +$4,464,210 41,690,775 +104% Charles Cherington 09 Jun 2025
Freebird Partners LP 9.9% -0.9% $1,304,421 +$225,715 6,211,530 +21% Freebird Partners LP 31 Mar 2025
HALPERN JOHN D 9.6% -3.9% $1,254,084 +$175,402 5,971,830 +16% John D. Halpern 31 Mar 2025
Konar Shameek 5.5% $721,414 3,435,304 Shameek Konar 31 Mar 2025
IAF, LLC 5.2% -0.4% $683,638 +$121,003 3,255,421 +22% IAF, LLC 31 Mar 2025
Singer Nicholas Jason 4.9% $538,650 2,565,001 Nicholas Jason Singer 31 Dec 2024

Institutional Holders of Ernexa Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$264,175 $0.18 0
2025 Q1 1,488,385 $264,200 +$76,046 $0.18 26
2024 Q4 994,393 $292,358 +$69,713 $0.29 24
2024 Q3 711,299 $746,882 +$337,331 $1.05 20
2024 Q2 390,079 $712,390 -$47,643 $1.83 19
2024 Q1 409,206 $982,076 +$130,770 $2.40 22
2023 Q4 355,004 $636,892 +$42,245 $1.80 19
2023 Q3 331,449 $728,429 -$4,855 $2.18 20
2023 Q2 333,250 $750,186 -$15,587 $2.26 19
2023 Q1 331,798 $1,135,164 +$6,895 $3.40 19
2022 Q4 329,815 $1,192,085 +$995,056 $3.22 18